Now, it’s worth noting Stock Advisor’s total average return is 986 % — a market-crushing outperformance compared to 199% for ...

On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

In this article, we will look at the 8 Most Undervalued Biotech Stocks to Buy Right Now.

We'll know more about the company's medium-term prospects by the end of the year.

This biotech company has a track record of commercializing products and delivering growth. It also has strengths in research and development. 10 stocks we like better than Regeneron Pharmaceuticals › ...

Legend Biotech Corporation (NASDAQ:LEGN) is one of the 10 Overlooked Growth Stocks to Buy Now. Legend Biotech Corporation ...

With the notable exceptions of Novo Nordisk A/S (NYSE: NVO) and Eli Lilly & Co. (NYSE: LLY), biotechnology stocks had a rough ...

Biogen is likely to get a big boost from its increased focus on developing drugs for kidney transplant patients and ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector's two major indexes - the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) - ...

Legend Biotech (NASDAQ: LEGN) was one of the healthier healthcare stocks on the market as the trading week kicked off on ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...